These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 385025)

  • 1. A single dose comparison of piretanide and bumetanide in congestive cardiac failure.
    Homeida M; Roberts CJ; Dombey SL
    Br J Clin Pharmacol; 1979 Aug; 8(2):173-8. PubMed ID: 385025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral piretanide in chronic renal failure.
    Henderson IS; Beattie TJ; Kennedy AC; Dombey SL
    Br J Clin Pharmacol; 1982 Dec; 14(6):857-60. PubMed ID: 7150461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure.
    Sherman LG; Liang CS; Baumgardner S; Charuzi Y; Chardo F; Kim CS
    Clin Pharmacol Ther; 1986 Nov; 40(5):587-94. PubMed ID: 3533372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure.
    Marone C; Rivera B; Zwahlen H; Lahn W; Frey F
    Eur J Clin Invest; 1989 Aug; 19(4):378-83. PubMed ID: 2506054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
    McNabb WR; Noormohamed FH; Lant AF
    Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bumetanide in congestive heart failure.
    Kourouklis C; Christensen O; Augoustakis D
    Curr Med Res Opin; 1976; 4(6):422-31. PubMed ID: 793779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ; Machnik H; Studt J; Fink R
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
    Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic action of bumetanide in congestive heart failure.
    Olsen KH; Sigurd B; Hesse B; Steiness E; Leth A
    Postgrad Med J; 1975; 51 Suppl 6():54-63. PubMed ID: 1105534
    [No Abstract]   [Full Text] [Related]  

  • 12. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP; Brogden RN
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.
    Marsh JD; Smith TW
    Pharmacotherapy; 1984; 4(4):170-80. PubMed ID: 6384944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR
    N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure.
    Konecke LL
    J Clin Pharmacol; 1981; 21(11):688-90. PubMed ID: 7040496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of piretanide and chlorothiazide in the treatment of cardiac failure.
    Gillies A; Morgan T; Myers J
    Med J Aust; 1980 Feb; 1(4):170-2. PubMed ID: 6990212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure.
    Marsh JD; Nesto R; Glynn MA; Smith TW
    J Cardiovasc Pharmacol; 1982; 4(6):949-54. PubMed ID: 6185787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure.
    Sigurd B; Olesen KH
    Acta Med Scand; 1978; 203(1-2):113-9. PubMed ID: 343509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular bumetanide and furosemide in congestive heart failure.
    Abrams J
    J Clin Pharmacol; 1981; 21(11):673-9. PubMed ID: 7338578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
    Hasenfuss G; Holubarsch C; Herzog C; Knauf H; Spahn H; Mutschler E; Just H
    Clin Cardiol; 1987 Feb; 10(2):83-8. PubMed ID: 3815928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.